Skip to main content
. 2010 Nov 23;5:112. doi: 10.1186/1748-717X-5-112

Table 1.

Patients' baseline characteristics.

Hypofractionation No. Conventional fractionation No. P
Age ≥ 60 ≥ 60 0.688
 Mean 71.9 71.6
 IQR 9 11

KPS 0.742
 100 34 40% 26 37%
 90 51 60% 44 63%

T stage 0.054
 1 70 82% 49 70%
 2 14 17% 21 30%
 3 1 1% 0 0%

N stage 0.045
 0 69 83% 47 67%
 1 16 17% 23 33%

Histologic type 0.357
 Ductal 66 77% 54 77%
 Lobular 13 15% 7 10%
 Others 6 8% 9 13%

Histologic grade 0.781
 1 17 20% 13 18%
 2 48 56% 37 54%
 3 20 24% 20 28%

Chemotherapy 0.375
 yes 19 22% 20 29%
 no 66 88% 50 71%

Hormone therapy 0.457
 yes 66 78% 50 71%
 no 19 22% 20 29%

Breast volume 0.039
 ≥ 500 cc 24 28% 29 41%
 < 500 cc 61 72% 41 59%

Breast maximum dose 0.0009
 > 107% ** 26 36% 40 65%
 ≤ 107% 59 64% 30 35%

Surgery 0.584
 Quadrantectomy 84 99% 68 97%
 Tumorectomy 1 1% 2 7%

IQR = interquartile range

KPS = Karnofsky performance status

T = tumor

N = lymph-node

** > 53.5 Gy for conventional fractionation and > 48.1 Gy for hypofractionation

P = chi-square test or Fisher's exact test